Science
Detailed tumour profiling – Science Daily
As part of a clinical study, researchers are conducting a thorough and highly precise investigation into the molecular and functional properties of tumors. Their…
Researchers from the University Hospitals in Zurich and Basel, ETH Zurich, University of Zurich and the pharmaceutical company Roche have set out to improve cancer diagnostics by developing a platform of state-of-the-art molecular biology methods. The “Tumor Profiler” project aims to derive the comprehensive molecular profile of tumours in cancer patients, which has the potential to predict the efficacy of a host of new cancer medications. It will therefore make it possible to offer treating physicians…
-
Noosa News22 hours agoBrisbane flights cancelled as severe weather set to lash coast
-
Business24 hours ago2 ASX ETFs to benefit from the resurgence of AI
-
Noosa News18 hours agoFormer Brisbane Lions sponsor goes bust, leaving 200 workers in limbo
-
Noosa News18 hours agoHero rescuer reveals terrifying details of horror shark attack at Cabarita Beach in NSW